Correlation Between Better Choice and Arcadia Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Better Choice and Arcadia Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Better Choice and Arcadia Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Better Choice and Arcadia Biosciences, you can compare the effects of market volatilities on Better Choice and Arcadia Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Better Choice with a short position of Arcadia Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Better Choice and Arcadia Biosciences.

Diversification Opportunities for Better Choice and Arcadia Biosciences

-0.28
  Correlation Coefficient

Very good diversification

The 3 months correlation between Better and Arcadia is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Better Choice and Arcadia Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcadia Biosciences and Better Choice is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Better Choice are associated (or correlated) with Arcadia Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcadia Biosciences has no effect on the direction of Better Choice i.e., Better Choice and Arcadia Biosciences go up and down completely randomly.

Pair Corralation between Better Choice and Arcadia Biosciences

Given the investment horizon of 90 days Better Choice is expected to under-perform the Arcadia Biosciences. In addition to that, Better Choice is 1.75 times more volatile than Arcadia Biosciences. It trades about -0.03 of its total potential returns per unit of risk. Arcadia Biosciences is currently generating about 0.04 per unit of volatility. If you would invest  242.00  in Arcadia Biosciences on August 29, 2024 and sell it today you would earn a total of  34.00  from holding Arcadia Biosciences or generate 14.05% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.52%
ValuesDaily Returns

Better Choice  vs.  Arcadia Biosciences

 Performance 
       Timeline  
Better Choice 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Better Choice has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Arcadia Biosciences 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Arcadia Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile fundamental indicators, Arcadia Biosciences may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Better Choice and Arcadia Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Better Choice and Arcadia Biosciences

The main advantage of trading using opposite Better Choice and Arcadia Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Better Choice position performs unexpectedly, Arcadia Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcadia Biosciences will offset losses from the drop in Arcadia Biosciences' long position.
The idea behind Better Choice and Arcadia Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Transaction History
View history of all your transactions and understand their impact on performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope